Targeting IL‐5 pathway against airway hyperresponsiveness: A comparison between benralizumab and mepolizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting IL‐5 pathway against airway hyperresponsiveness: A comparison between benralizumab and mepolizumab

Published:2020-09-17 Issue:20 Volume:177 Page:4750-4765
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Calzetta Luigino¹^ORCID,Ritondo Beatrice Ludovica¹,Matera Maria Gabriella²^ORCID,Facciolo Francesco³,Rogliani Paola¹^ORCID

Affiliation:

1. Unit of Respiratory Medicine, Department of Experimental Medicine University of Rome “Tor Vergata” Rome Italy

2. Unit of Pharmacology, Department of Experimental Medicine University of Campania “Luigi Vanvitelli” Naples Italy

3. Thoracic Surgery Unit Regina Elena National Cancer Institute Rome Italy

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15240

Reference64 articles.

1. Treatable traits: toward precision medicine of chronic airway diseases

2. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Catalytic receptors

3. Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma

4. The cellular biology of eosinophil eicosanoid formation and function

5. New Anti-Eosinophil Drugs for Asthma and COPD

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigational thymic stromal lymphopoietin inhibitors for the treatment of asthma: a systematic review;Expert Opinion on Investigational Drugs;2024-01-02

2. Use of human airway smooth muscle in vitro and ex vivo to investigate drugs for the treatment of chronic obstructive respiratory disorders;British Journal of Pharmacology;2023-12-20

3. Engineering bispecific T-cell engagers to deplete eosinophils for the treatment of severe eosinophilic asthma;Clinical Immunology;2023-10

4. Post-marketing safety of anti-IL-5 monoclonal antibodies (mAbs): an analysis of the FDA Adverse Event Reporting System (FAERS);Expert Opinion on Drug Safety;2023-08-29

5. Eosinophil depletion with benralizumab is associated with attenuated mannitol airway hyperresponsiveness in severe uncontrolled eosinophilic asthma;Journal of Allergy and Clinical Immunology;2023-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3